Will a Life Insurance Company Reject You for Slightly Elevated SGOP and SGPT Liver Enzymes?

How Life Insurers View SGOP and SGPT

Life insurance underwriters treat elevated SGOP and SGPT—markers of liver stress—like any medical test that suggests potential health risks. A modest rise often triggers a more detailed review but is rarely an automatic denial.

Typical Thresholds and Their Meaning

Insurers set cutoffs that vary by carrier and policy type. A common upper limit is 2–2.5 times the upper reference limit (URL). Values between 1.5 and 2.5× URL typically prompt a medical questionnaire but rarely lead to a refusal.

Factors That Influence the Decision

• Duration of Elevation: Persistent high levels over years raise concern more than a single abnormal reading.
• Underlying Cause: Documented reasons such as medication side effects or viral hepatitis history can mitigate risk.
• Overall Health Profile: Absence of other comorbidities (e.g., diabetes, hypertension) helps offset liver enzyme concerns.

What Rejection Might Look Like

Insurers may offer a policy at a higher premium, impose a medical policy (requiring ongoing doctor visits), or, in rare cases, refuse coverage if the enzymes suggest severe liver disease or if the applicant has a history of alcohol misuse.

How to Improve Your Chances

• Provide recent test results and a physician's note explaining the elevation.
• Show evidence of treatment or lifestyle changes that lowered the enzymes.
• Consider a pre-application medical exam with a specialist to confirm liver health.

Alternatives if Rejected

Short-term policies or group coverage may be available, and some insurers specialize in high-risk applicants. Consulting a broker can reveal options tailored to liver enzyme concerns.